EUVIMEDEUVIMED entdecken
Crossref

miR‑214‑3p facilitates keloid development via targeting FOXO3 and indicates recurrence risk

Peipei Gao, Xing Guo, Jinghe Zhou, Weizhe Li

Archives of Dermatological Research · 17.11.2026 · 318 (1)

DOI: 10.1007/s00403-026-05036-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 17.11.2026. Verfasst von Peipei Gao und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keloid is a treatment-resistant fibroproliferative skin disease marked by excessive fibroblast activation, chronic inflammation, and dysregulated extracellular matrix deposition. This study aimed to identify a novel circulating and tissue‑based biomarker, clarify its functional mechanism, and evaluate its prognostic value in keloid. Thirty keloid tissues and thirty normal skin tissues were enrolled. The expression of miR‑214‑3p and FOXO3 mRNA was detected by Real Time quantitative PCR. The correlation of miR‑214‑3p with inflammatory factors and keloid recurrence was analyzed. Gain‑ and loss‑of‑function assays, dual‑luciferase reporter assay, and rescue experiments were performed in human keloid fibroblasts (KFs). miR‑214‑3p was markedly overexpressed in keloid tissues and KFs, with expression positively correlated with IL‑6, TNF‑α and IL‑1β. ROC analysis revealed its moderate predictive potential for keloid postoperative recurrence (AUC = 0.785, P = 0.01). miR‑214‑3p upregulation facilitated KF proliferation, migration, invasion and inflammatory factor secretion while restraining apoptosis, and miR‑214‑3p depletion induced inverse phenotypes. Rescue assays confirmed FOXO3 silencing partially offset the suppressive influence of miR‑214‑3p inhibition on aberrant KF biological behaviors. miR‑214‑3p promotes keloid progression by targeting FOXO3 and is associated with postoperative recurrence, suggesting its potential as a prognostic biomarker. The miR‑214‑3p/FOXO3 axis may represent a potential therapeutic target for keloid, although further in vivo validation is required.

Zitieren

APA

Gao, P., Guo, X., Zhou, J., & Li, W. (2026). miR‑214‑3p facilitates keloid development via targeting FOXO3 and indicates recurrence risk. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-05036-1

Vancouver

Gao P, Guo X, Zhou J, Li W. miR‑214‑3p facilitates keloid development via targeting FOXO3 and indicates recurrence risk. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-05036-1

BibTeX
@article{Gao2026,
  author = {Gao, Peipei and Guo, Xing and Zhou, Jinghe and Li, Weizhe},
  title = {miR‑214‑3p facilitates keloid development via targeting FOXO3 and indicates recurrence risk},
  journal = {Archives of Dermatological Research},
  year = {2026},
  volume = {318},
  number = {1},
  doi = {10.1007/s00403-026-05036-1}
}
Kostenlos starten →